Is Gilead Sciences' Sudden Change in Leadership a Good Thing?

Gilead Sciences (NASDAQ:GILD) announced last week that CEO John Milligan and Chairman John Martin will step down from their respective positions later this year. In March, the biotech's Chief Scientific Officer Norbert Bischofberger also decided to vacate his position to pursue other opportunities.